pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Cardiology · news · pharmadog
← back to Cardiology
News · Cardiology
793
stories
7d
Rezera postpones a planned $200M IPO shortly before expected debut
endpoints
7d
Deep dive: Cardiovascular calamities and catalysts
biospace
7d
Blackstone bets $1.5B on Pfizer’s obesity drug
biopharma dive
7d
Game Changer Products LLC Issues Voluntary Nationwide Recall of 10 Day Forecast Capsules Due to the Presence of Undeclared Sildenafil and Acetaminophen
fda recalls
7d
STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment
stat
7d
Eros Apothecary Issues Recall of Candy Power For Man Organic Honey Due to Undeclared Tadalafil
fda recalls
7d
Bristol Myers research chief to depart in ‘evolution’ of company’s structure
biopharma dive
7d
American Cancer Society revises guidelines, urges routine PSA screening for prostate cancer
stat
7d
STAT+: What to know about Biogen’s big lupus study readout
stat
7d
STAT+: Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem
stat
8d
STAT+: Why this former ER doc thinks giving AI less information is sometimes better
stat
8d
Capricor parts ways with 10% of staff as FDA decision on DMD cell therapy nears
biospace
8d
The U.S. may soon lose measles elimination status
stat
8d
Novartis’ Zolgensma woes, BIO’s China plan, GLP-1s’ new safety warning, FDA’s stacked November
biospace
8d
A new tactic in the war over out-of-network bills: Health care providers are suing employers
stat
8d
Valo and Montai become one as the Flagship AI-based biotechs tie the knot
fiercebiotech
8d
Capricor, NextCure shed light on recent layoffs as they gear up for approval decision, merger
fiercebiotech
9d
Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator lead
fiercebiotech
9d
PepGen soars on promising early data for muscular dystrophy drug
biopharma dive
9d
STAT+: Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug
stat
9d
Bayer wins first-in-class FDA nod for blood thinner, setting stage for BMS-J&J rival
biospace
9d
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
stat
9d
STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more
stat
9d
STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
stat
9d
STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds
stat
9d
Why this year’s flu season could be hitting teens and young adults hard
stat
9d
STAT+: PepGen says early trial for muscular dystrophy drug looks promising
stat
10d
STAT+: Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug
stat
10d
Bayer wins FDA nod for a new kind of blood thinner
biopharma dive
10d
STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
stat
← prev
page 2 of 27
next →